The 2017 Annual Data Report details industry - specific statistics and trends from more than 850 leading cell therapy, gene therapy, tissue engineering, and other regenerative
medicine companies worldwide.
San Diego, California, October 29, 2013 — ViaCyte, Inc., a leading regenerative
medicine company focused on developing new approaches to treat major diseases through the application of a stem cell - derived cell therapy, announced today that the Company was granted over 20 patents worldwide in 2013 thus far, three U.S. and twenty f
company focused on developing new approaches to treat major diseases through the application of a stem cell - derived cell therapy, announced today that the
Company was granted over 20 patents worldwide in 2013 thus far, three U.S. and twenty f
Company was granted over 20 patents
worldwide in 2013 thus far, three U.S. and twenty foreign.
Invivoscribe Technologies Inc. is a privately held biotechnology
company dedicated to improving the quality of healthcare
worldwide by providing high quality, reliable, cutting - edge reagents, tests, and bioinformatics tools to advance the fields of personalized molecular diagnostics ® and personalized molecular
medicine.